#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Denis Kay Email
Co-Founder & Chief Scientific Officer at Alpha Cognition Inc. . Alpha Cognition
Vancouver, BC
LocationPrimary Email
How to contact Denis Kay
Join and see Denis's contact info for free!Current Roles
Employees:
7Revenue:
$703.5kAbout
Alpha Cognition is a clinical stage, biopharmaceutical company dedicated to developing novel treatments for under-served neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS). ALPHA-1062, a patented new chemical entity that has demonstrated safety and improved tolerability in human clinical trials. It is being developed as a new acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer’s type, with minimal gastrointestinal side-effects and novel routes of administration. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS. ALPHA-0602 is patented and has received Orphan Drug Designation from the FDA.Alpha Cognition Address
439 Helmcken StreetVancouver, BC
CAN